Which of the following are described as the key objectives of a Phase I trial, regardless of drug?

4.
Question 4
Which of the following are described as the key objectives of a Phase I trial, regardless of drug?

1 point

assess appropriateness of stopping rules

determine inclusion/exclusion recommendations

characterize the pharmacokinetic (PK) profile

assess safety and tolerability